Clinical Trial Update: Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients [Phase 1, Phase 2]

View source ↗

Summary

An early-phase study evaluating bacteriophage therapy for recurrent urinary tract infections in kidney transplant recipients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection Recurrent

Drugs mentioned

• Phage therapy

Snippet

Sponsor: University of California, San Diego | Conditions: Urinary Tract Infection, Recurrent | Phase 1, Phase 2 | Status: RECRUITING